Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type (Pure Platelet Rich Plasma, Leukocyte Rich), By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Platelet Rich Plasma Market Growth & Trends
The global platelet rich plasma market size is expected to reach USD 1.94 billion by 2030, registering a CAGR of 15.11% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.
Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.
Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body’s own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient’s cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.
Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company’s product portfolio and improved its market presence.
In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2021, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.
Platelet Rich Plasma Market Report Highlights
Platelet Rich Plasma Market Growth & Trends
The global platelet rich plasma market size is expected to reach USD 1.94 billion by 2030, registering a CAGR of 15.11% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.
Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.
Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body’s own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient’s cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.
Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company’s product portfolio and improved its market presence.
In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2021, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.
Platelet Rich Plasma Market Report Highlights
- By type, the pure platelet-rich plasma segment held the largest revenue share of over 50.0% in 2021 due to its widespread use across various therapeutic areas and rising demand for its off-label uses worldwide
- By application, the orthopedics segment dominated the market in 2021 due to an upsurge in the number of research studies to investigate PRP across various applications in orthopedics. However, other segments such as dermatology, sports medicine, and ulcer healing are expected to grow at a faster rate over the forecast period
- The hospitals end-use segment held the largest revenue share in 2021. This can be attributed to an increase in the number of hospitals delivering PRP-based therapies and rising number of knee osteoarthritis cases in recent years
- North America dominated the global market in 2021 due to wider applications of RPP, rising awareness about PRP-based treatments, and increasing number of orthopedics incidences
- Asia Pacific is expected to grow considerably in the future owing to rising number of cosmetic surgeries and growing medical tourism industry
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 GVR’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details of Primary Research
1.6 Information or Data Analysis
1.6.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
1.6.2 sports medicine market: segment revenue and growth analysis
1.6.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
1.6.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
1.6.3.1.1 Non-Healing Ulcers
1.6.3.1.1.1 Diabetic Ulcers
1.6.3.1.1.2 Pressure Ulcers
1.6.3.1.1.3 Pyoderma gangrenosum
1.6.3.1.1.4 Venous ulcers
1.6.4 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.9 Market: CAGR Calculation
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 Objectives
1.12.1 Objective
1.12.2 Objective
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Outlook
3.2 Market Summary
CHAPTER 4 HOST CELL CONTAMINANT TESTING MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Trends & Outlook
4.2 Market Segmentation & Scope
4.3 Market Driver Analysis
4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
4.3.2 Increasing Regulatory Focus On Host Cell Contaminant Detection
4.3.3 extending Medical Applications Of Platelet Rich Plasma
4.3.4 Increasing Number Of Evidence-Based Studies For Prp-Based Wound Healing
4.4 Market Restraint Analysis
4.4.1 high Costs Associated With Prp Products
4.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
4.6 Porter’s Five Forces Analysis
4.7 COVID-19 Impact Analysis
4.8 Penetration & Growth Prospect Mapping
CHAPTER 5 PLATELET RICH PLASMA MARKET - SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)
5.1 Platelet Rich PlasmaMarket: Type Movement Analysis
5.2 Pure PRP
5.2.1 Pure Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 leukocyte Rich Prp
5.3.1 leukocyte Rich Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Other Type Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 PLATELET RICH PLASMA MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 platelet Rich Plasmamarket: Application Movement Analysis
6.2 Orthopedics
6.2.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Sports Medicine
6.3.1 Sport Medicine market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Cosmetic Surgery
6.4.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Cosmetic Surgery, 2018 - 2030
6.5 Dermatology
6.5.1 Coverage Scenario: U.S. Centers For Medicare & Medicaid Services
6.5.2 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Dermatology, 2018 - 2030
6.5.3 Ulcer healing
6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 - 2030
6.5.3.2 Venous ulcers
6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 - 2030
6.5.3.3 Traumatic ulcers
6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 - 2030
6.5.3.4 Pyoderma gangrenosum ulcers
6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030
6.5.3.5 Diabetic ulcers
6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 - 2030
6.5.3.6 Trophic ulcers
6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 - 2030
6.5.3.7 Vasculitic ulcers
6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030
6.5.4 Others
6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 - 2030
6.6 Ophthalmic Surgery
6.6.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Ophthalmic Surgery, 2018 - 2030
6.7 Neurosurgery
6.7.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Neurosurgery, 2018 - 2030
6.8 General Surgery
6.8.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For General Surgery, 2018 - 2030
6.9 Others
6.9.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Others, 2018 - 2030
CHAPTER 7 PLATELET RICH PLASMA (PRP) MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
7.2 Hospitals
7.2.1 Hospitals market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Clinics
7.3.1 Clinics market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 PLATELET RICH PLASMA (PRP) MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East And Africa
8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 UAE
8.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILE
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Johnson & Johnson
9.3.1.1 Company overview
9.3.1.2 DePuy Synthes
9.3.1.2.1 Company overview
9.3.1.3 Financial Performance
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 Arthrex, Inc.
9.3.2.1 Company overview
9.3.2.2 Financial Performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 EmCyte Corporation
9.3.3.1 Company overview
9.3.3.2 Product benchmarking
9.3.3.3 Strategic initiatives
9.3.4 DR. PRP AMERICA, LLC
9.3.4.1 Company overview
9.3.4.2 Product benchmarking
9.3.5 Juventix
9.3.5.1 Company overview
9.3.5.2 Financial Performance
9.3.5.3 Product benchmarking
9.3.6 Terumo Corporation
9.3.6.1 Company overview
9.3.6.2 TERUMO BCT, INC.
9.3.6.2.1 Company overview
9.3.6.3 Financial Performance
9.3.6.4 Product benchmarking
9.3.6.5 Strategic initiatives
9.3.7 Zimmer Biomet
9.3.7.1 Company overview
9.3.7.2 Financial Performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Stryker
9.3.8.1 Company overview
9.3.8.2 Financial Performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Apex Biologix
9.3.9.1 Company overview
9.3.9.2 Financial Performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Celling Biosciences
9.3.10.1 Company overview
9.3.10.2 Financial Performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Purchased Database
1.5.2 GVR’s Internal Database
1.5.3 Secondary Sources
1.5.4 Primary Research
1.5.5 Details of Primary Research
1.6 Information or Data Analysis
1.6.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
1.6.2 sports medicine market: segment revenue and growth analysis
1.6.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
1.6.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
1.6.3.1.1 Non-Healing Ulcers
1.6.3.1.1.1 Diabetic Ulcers
1.6.3.1.1.2 Pressure Ulcers
1.6.3.1.1.3 Pyoderma gangrenosum
1.6.3.1.1.4 Venous ulcers
1.6.4 Data Analysis Models
1.7 Market Formulation & Validation
1.8 Model Details
1.8.1 Commodity Flow Analysis
1.8.1.1 Approach 1: Commodity Flow Approach
1.8.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.9 Market: CAGR Calculation
1.10 List of Secondary Sources
1.11 List of Primary Sources
1.12 Objectives
1.12.1 Objective
1.12.2 Objective
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Outlook
3.2 Market Summary
CHAPTER 4 HOST CELL CONTAMINANT TESTING MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Trends & Outlook
4.2 Market Segmentation & Scope
4.3 Market Driver Analysis
4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
4.3.2 Increasing Regulatory Focus On Host Cell Contaminant Detection
4.3.3 extending Medical Applications Of Platelet Rich Plasma
4.3.4 Increasing Number Of Evidence-Based Studies For Prp-Based Wound Healing
4.4 Market Restraint Analysis
4.4.1 high Costs Associated With Prp Products
4.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
4.6 Porter’s Five Forces Analysis
4.7 COVID-19 Impact Analysis
4.8 Penetration & Growth Prospect Mapping
CHAPTER 5 PLATELET RICH PLASMA MARKET - SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)
5.1 Platelet Rich PlasmaMarket: Type Movement Analysis
5.2 Pure PRP
5.2.1 Pure Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 leukocyte Rich Prp
5.3.1 leukocyte Rich Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Other Type Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 6 PLATELET RICH PLASMA MARKET - SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)
6.1 platelet Rich Plasmamarket: Application Movement Analysis
6.2 Orthopedics
6.2.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Sports Medicine
6.3.1 Sport Medicine market Estimates And Forecast, 2018 - 2030 (USD Million)
6.4 Cosmetic Surgery
6.4.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Cosmetic Surgery, 2018 - 2030
6.5 Dermatology
6.5.1 Coverage Scenario: U.S. Centers For Medicare & Medicaid Services
6.5.2 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Dermatology, 2018 - 2030
6.5.3 Ulcer healing
6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 - 2030
6.5.3.2 Venous ulcers
6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 - 2030
6.5.3.3 Traumatic ulcers
6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 - 2030
6.5.3.4 Pyoderma gangrenosum ulcers
6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030
6.5.3.5 Diabetic ulcers
6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 - 2030
6.5.3.6 Trophic ulcers
6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 - 2030
6.5.3.7 Vasculitic ulcers
6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030
6.5.4 Others
6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 - 2030
6.6 Ophthalmic Surgery
6.6.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Ophthalmic Surgery, 2018 - 2030
6.7 Neurosurgery
6.7.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Neurosurgery, 2018 - 2030
6.8 General Surgery
6.8.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For General Surgery, 2018 - 2030
6.9 Others
6.9.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Others, 2018 - 2030
CHAPTER 7 PLATELET RICH PLASMA (PRP) MARKET - SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)
7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
7.2 Hospitals
7.2.1 Hospitals market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3 Clinics
7.3.1 Clinics market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Others
7.4.1 Others market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 8 PLATELET RICH PLASMA (PRP) MARKET - SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.4 Spain
8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.5 France
8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.3.6 Italy
8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.2 Japan
8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.3 China
8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.4.6 Australia
8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Middle East And Africa
8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.3 UAE
8.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILE
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Johnson & Johnson
9.3.1.1 Company overview
9.3.1.2 DePuy Synthes
9.3.1.2.1 Company overview
9.3.1.3 Financial Performance
9.3.1.4 Product benchmarking
9.3.1.5 Strategic initiatives
9.3.2 Arthrex, Inc.
9.3.2.1 Company overview
9.3.2.2 Financial Performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 EmCyte Corporation
9.3.3.1 Company overview
9.3.3.2 Product benchmarking
9.3.3.3 Strategic initiatives
9.3.4 DR. PRP AMERICA, LLC
9.3.4.1 Company overview
9.3.4.2 Product benchmarking
9.3.5 Juventix
9.3.5.1 Company overview
9.3.5.2 Financial Performance
9.3.5.3 Product benchmarking
9.3.6 Terumo Corporation
9.3.6.1 Company overview
9.3.6.2 TERUMO BCT, INC.
9.3.6.2.1 Company overview
9.3.6.3 Financial Performance
9.3.6.4 Product benchmarking
9.3.6.5 Strategic initiatives
9.3.7 Zimmer Biomet
9.3.7.1 Company overview
9.3.7.2 Financial Performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Stryker
9.3.8.1 Company overview
9.3.8.2 Financial Performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Apex Biologix
9.3.9.1 Company overview
9.3.9.2 Financial Performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Celling Biosciences
9.3.10.1 Company overview
9.3.10.2 Financial Performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
LIST OF TABLES
Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 19 U.K. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 20 U.K. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 21 U.K. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 39 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 40 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 41 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 42 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 43 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 44 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 45 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 46 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 48 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 49 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 50 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 51 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 52 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 53 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 54 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 55 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 56 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 57 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 58 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 59 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 60 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 61 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 62 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 63 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 64 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 65 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 67 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 68 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 69 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 70 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 71 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 73 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 74 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 75 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 19 U.K. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 20 U.K. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 21 U.K. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 36 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 37 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 39 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 40 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 41 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 42 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 43 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 44 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 45 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 46 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 47 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 48 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 49 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 50 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 51 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 52 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 53 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 54 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 55 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 56 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 57 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 58 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 59 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 60 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 61 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 62 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 63 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
Table 64 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 65 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 66 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 67 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 68 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 69 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 70 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 71 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 72 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
Table 73 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
Table 74 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
Table 75 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 PRP segment revenue modeling
Fig. 5 Sports medicine market segment revenue modeling
Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
Fig. 8 Market research approaches
Fig. 9 Value chain-based sizing & forecasting
Fig. 10 QFD modeling for market share assessment
Fig. 11 Market formulation & validation
Fig. 12 Platelet rich plasma (PRP) market snapshot, 2021 (USD Million)
Fig. 13 Platelet rich plasma (PRP) market segmentation
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
Fig. 16 Incidence of arthritis in U.S., by age
Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
Fig. 19 Common cosmetic surgical procedures in 2019
Fig. 20 Cosmetic plastic demographic data in 2019
Fig. 21 Common minimal invasive procedures in 2019, U.S.
Fig. 22 Number of customers for cosmetic surgery in China (Million)
Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
Fig. 24 Market restraint relevance analysis (Current & future impact)
Fig. 25 Market opportunity relevance analysis (Current & future impact)
Fig. 26 Penetration and growth prospect mapping, by Application, 2021
Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
Fig. 28 Platelet rich plasma (PRP) market Porter’s five forces analysis
Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
Fig. 31 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
Fig. 42 Categorization of studies based on types of ulcers
Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
Fig. 44 Meta-analysis of lower extremity venous ulcers
Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
Fig. 48 Results obtained for individuals treated with PRP-Part A
Fig. 49 Results obtained for individuals treated with PRP-Part B
Fig. 50 Results obtained for individuals treated with PRP-Part C
Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
Fig. 53 Reduction in the surface area of trophic ulcers
Fig. 54 Reduction in the surface area of trophic ulcers
Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
Fig. 66 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
Fig. 67 Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
Fig. 70 Strategy framework
Fig. 71 Market participation categorization
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 PRP segment revenue modeling
Fig. 5 Sports medicine market segment revenue modeling
Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
Fig. 8 Market research approaches
Fig. 9 Value chain-based sizing & forecasting
Fig. 10 QFD modeling for market share assessment
Fig. 11 Market formulation & validation
Fig. 12 Platelet rich plasma (PRP) market snapshot, 2021 (USD Million)
Fig. 13 Platelet rich plasma (PRP) market segmentation
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
Fig. 16 Incidence of arthritis in U.S., by age
Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
Fig. 19 Common cosmetic surgical procedures in 2019
Fig. 20 Cosmetic plastic demographic data in 2019
Fig. 21 Common minimal invasive procedures in 2019, U.S.
Fig. 22 Number of customers for cosmetic surgery in China (Million)
Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
Fig. 24 Market restraint relevance analysis (Current & future impact)
Fig. 25 Market opportunity relevance analysis (Current & future impact)
Fig. 26 Penetration and growth prospect mapping, by Application, 2021
Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
Fig. 28 Platelet rich plasma (PRP) market Porter’s five forces analysis
Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
Fig. 31 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
Fig. 42 Categorization of studies based on types of ulcers
Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
Fig. 44 Meta-analysis of lower extremity venous ulcers
Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
Fig. 48 Results obtained for individuals treated with PRP-Part A
Fig. 49 Results obtained for individuals treated with PRP-Part B
Fig. 50 Results obtained for individuals treated with PRP-Part C
Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
Fig. 53 Reduction in the surface area of trophic ulcers
Fig. 54 Reduction in the surface area of trophic ulcers
Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
Fig. 66 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
Fig. 67 Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
Fig. 70 Strategy framework
Fig. 71 Market participation categorization
